Feasibility and acceptability of daily oral emtricitabine/tenofovir alafenamide fumarate (FTC/TAF) for HIV pre-exposure prophylaxis among people who inject drugs with opioid use disorder
Authors
Jeffrey A. Wickersham (ORCID: https://orcid.org/0000-0001-7701-9162)
Feasibility and acceptability of daily oral emtricitabine/tenofovir alafenamide fumarate (FTC/TAF) for HIV pre-exposure prophylaxis among people who inject drugs with opioid use disorder
Jeffrey A. Wickersham, Luzan JadKarim, Roman Shrestha, Kiran Paudel et al.
Journal
Sexually Transmitted Infections
Topics
HIV, Drug Use, Sexual Risk
article
Feasibility and acceptability of daily oral emtricitabine/tenofovir alafenamide fumarate (FTC/TAF) for HIV pre-exposure prophylaxis among people who inject drugs with opioid use disorder
Jeffrey A. Wickersham, Luzan JadKarim, Roman Shrestha, Kiran Paudel, Zeyan Liew, Michael Copenhaver, Antoine Khati, Frederick L Altice, Kamal Gautam, Giselle Bellia
article en
Abstract
No abstract available for this paper.
Publication Tag
Sexually Transmitted Infections
Institutions
University of Connecticut (US), Yale University (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Feasibility and acceptability of daily oral emtricitabine/tenofovir alafenamide fumarate (FTC/TAF) for HIV pre-exposure prophylaxis among people who inject drugs with opioid use disorder — Jeffrey A. Wickersham, Luzan JadKarim, et al. · Sexually Transmitted Infections (2026) | TGRS Research Map | TGRS